Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor

Aug. 28, 2018

Cathepsin S inhibitors discovered at Astellas

Aug. 23, 2018

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Aug. 22, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery

Aug. 13, 2018

Uncovering the function of Cep57 in mosaic-variegated aneuploidy syndrome

Aug. 13, 2018

BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group

July 30, 2018

Vasopressin inhibition decreases mortality in jet-lagged mice

July 24, 2018

Fixing nuclear transport helps cells cope with premature, normal aging

July 11, 2018

Celtaxsys divulges new LTA-4 hydrolase inhibitors

July 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...